Callan Capital, LLC Merck & Co., Inc. Transaction History

Callan Capital, LLC

  • $1.35 Billion
  • Q1 2025

A detailed history of Callan Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Callan Capital, LLC holds 11,927 shares of MRK stock, worth $907,167. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,927
Previous 12,395 3.78%
Holding current value
$907,167
Previous $1.23 Million 13.22%
% of portfolio
0.08%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025
SELL
$83.01 - $101.02 $38,848 - $47,277
-468 Reduced 3.78%
11,927 $1.07 Million
Q4 2024

Feb 03, 2025
BUY
$96.31 - $114.76 $170,468 - $203,125
1,770 Added 16.66%
12,395 $1.23 Million
Q3 2024

Nov 12, 2024
SELL
$111.15 - $128.97 $39,458 - $45,784
-355 Reduced 3.23%
10,625 $1.21 Million
Q2 2024

Aug 12, 2024
BUY
$123.8 - $132.96 $146,950 - $157,823
1,187 Added 12.12%
10,980 $1.36 Million
Q1 2024

Oct 22, 2024
SELL
$113.24 - $131.95 $134,415 - $156,624
-1,187 Reduced 10.81%
9,793 $1.29 Million
Q1 2024

May 03, 2024
BUY
$113.24 - $131.95 $235,199 - $274,060
2,077 Added 26.92%
9,793 $1.29 Million
Q4 2023

Feb 02, 2024
BUY
$100.18 - $109.02 $33,259 - $36,194
332 Added 4.5%
7,716 $841,000
Q3 2023

Nov 06, 2023
BUY
$102.95 - $114.33 $43,444 - $48,247
422 Added 6.06%
7,384 $760,000
Q2 2023

Aug 04, 2023
SELL
$108.61 - $118.38 $123,163 - $134,242
-1,134 Reduced 14.01%
6,962 $803,000
Q1 2023

Jun 13, 2023
BUY
$102.94 - $114.86 $7,720 - $8,614
75 Added 0.94%
8,096 $861,000
Q1 2023

May 08, 2023
BUY
$102.94 - $114.86 $7,720 - $8,614
75 Added 0.94%
8,096 $861,000
Q4 2022

Jun 13, 2023
SELL
$87.44 - $112.11 $6,558 - $8,408
-75 Reduced 0.93%
8,021 $889,000
Q4 2022

Feb 13, 2023
BUY
$87.44 - $112.11 $305,690 - $391,936
3,496 Added 77.26%
8,021 $889,000
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $50,548 - $56,786
598 Added 15.23%
4,525 $390,000
Q1 2022

May 10, 2022
BUY
$73.51 - $82.4 $6,248 - $7,004
85 Added 2.21%
3,927 $322,000
Q4 2021

Jan 21, 2022
BUY
$72.28 - $90.54 $5,782 - $7,243
80 Added 2.13%
3,842 $294,000
Q3 2021

Oct 15, 2021
SELL
$71.68 - $78.83 $7,168 - $7,883
-100 Reduced 2.59%
3,762 $283,000
Q2 2021

Aug 10, 2021
BUY
$70.31 - $77.77 $7,031 - $7,777
100 Added 2.66%
3,862 $300,000
Q1 2020

May 08, 2020
BUY
$63.36 - $87.82 $238,360 - $330,378
3,762 New
3,762 $289,000

Others Institutions Holding MRK

# of Institutions
3,888
Shares Held
1.93B
Call Options Held
26.2M
Put Options Held
23.5M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $193B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email